FDA Investigator: Charles Cote
- Charles Cote first started conducting FDA inspections in 2000, with the last inspection in 2013. Over that time, Charles Cote has conducted 321 inspections at 201 companies across 221 sites.
Get Charles Cote's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Scientific Protein Laboratories, Waunakee | Sep 2010
Available Now - $199
Charles Cote
Human Drug Form 483
FDA 483 Veterinary Pharmacy Corporation, Saint Peter | 2013
Out-of-stock
Charles Cote
Animal Drugs & Feed Form 483
FDA 483 University of North Dakota, Sch of Medicine & Hth Science, Grand Forks | 2013
Out-of-stock
Charles Cote
Human Drug Form 483
FDA 483 Wisconsin Medical Cyclotron LLC, West Allis | 2013
Out-of-stock
Charles Cote
Human Drug Form 483
FDA 483 Amgen Technology Ireland, Dun Laoghaire, Dublin | 2013
Out-of-stock
Charles Cote
Human Drug Form 483
FDA 483 Amgen Technology Ireland, Glenageary | 2013
Out-of-stock
Charles Cote
Human Drug Form 483
FDA 483 Labor L&s Ag, Bad Bocklet | 2013
Out-of-stock
Charles Cote
Human Drug Form 483
FDA 483 AllerQuest LLC, Plainville | 2012
Out-of-stock
Charles Cote
Human Drug Form 483
FDA 483 Fuller's Milker Center, Inc, Lancaster | 2012
Out-of-stock
Charles Cote
Animal Drugs & Feed Form 483
FDA 483 Cardinal Health, Roseville | 2012
Out-of-stock
Charles Cote
Human Drug Form 483
FDA 483 PETNET Solutions, Inc., Minneapolis | 2012
Out-of-stock
Charles Cote
Human Drug Form 483
FDA 483 Nephron Pharmaceuticals Corp., Orlando | 2012
Out-of-stock
Charles Cote
Human Drug Form 483
FDA 483 Kleen Test Products Corporation, Port Washington | 2012
Out-of-stock
Charles Cote
Human Drug Form 483
FDA 483 Accelerated Analytical Laboratories Inc., Milwaukee | 2012
Out-of-stock
Charles Cote
Human Drug Form 483
Co-Investigators (43)
- Justin A. Boyd, FDA Investigator
- Sandra A. Hughes, FDA Investigator
- Michael R. Klapal, FDA Investigator
- Brenda W. Uratani, FDA Investigator
- Angela E. Glenn, FDA Investigator
- Eric A. Breselow, FDA Investigator
- Jasjeet K. Sekhon, FDA Investigator
- Susan M. Miller, FDA Investigator
- Jesse P. Romenesko, FDA Investigator
- April L. Young, FDA Investigator
- Corey K. Reno, FDA Investigator
- Kimberly W. Destromp, FDA Investigator
- Susan M. Jackson, FDA Investigator
- Amy L. McIntyre, FDA Investigator
- Dacia E. Quick, FDA Investigator
- Jonathan L. Blonk, FDA Investigator
- Jessica L. Barr, FDA Investigator
- Kailas Nagaraj, FDA Investigator
- Justin J. Jafferis, FDA Investigator
- Ivan E. Reyes, FDA Investigator
- Joel D. Hustedt, FDA Investigator
- Peter T. Erlandson, FDA Investigator
- Tara M. Carolfi, FDA Investigator
- Diane T. Reindl, FDA Investigator
- Aaron L. Dunbar, FDA Investigator
- Scott B. Laufenberg, FDA Investigator
- Sarah A. Palmer, FDA Investigator
- Howard A. Burmester, FDA Investigator
- Denise L. Burosh, FDA Investigator
- Jeffery A. Hangartner, FDA Investigator
- Ronald R. Ruff, FDA Investigator
- Christine Twohy, FDA Investigator
- Craig R. Berger, FDA Investigator
- Mary-Ann Ruff, FDA Investigator
- Donald L. Lech, FDA Investigator
- Marie A. Fadden, FDA Investigator
- Jon C. Polzine, FDA Investigator
- Edmond J. Baratta, FDA Investigator
- Dennis Cantellops Paite, FDA Investigator
- Cantellops Paite, Dennis, FDA Investigator
- Gregory W. Smith, FDA Investigator
- Lisa M. Lopez, FDA Investigator
- Chris A. Sack, FDA Investigator